Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 946-959-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Two endpoints (skin irritation) are available.
1) In Vitro EpiDermTM
The test was performed according to the OECD Test Guideline No. 439: In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method (2015) and Protocol for: In Vitro EpiDermTMSkin Irritation Test For use with MatTek Corporation’s Reconstructed Human Epidermal Model EPI-200-SIT. GLP study, Klimish score 1.
Value: The effect of the test substance was positive in EpiDermTMmodel (tissues were damaged). The test substance is identified as requiring classification and labelling according to UN GHS (Category 2 or Category 1).
As the test substance was not tested for skin corrosion, it is not possible to decide between these two categories.
2) QSAR Toolbox prediction: Model name: BfR skin irritation/corrosion
Predicted value: not irritating or corrosive to skin
Two endpoints (eye irritation) are available.
1) BCOP
The test was performed according to the OECD Test Guideline No. 437, Bovine Corneal Opacity and Permeability Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage, Adopted 26thJuly 2013.
The basic values for the IVIS calculation (opacity values) could not be measured because of dark black colouring of corneas which were applied by the test substance. The In Vitro Irritancy Score (IVIS) for test substance, Acid Black 227, could not be calculated. For this reason, the classification was not performed. The results of permeability showed damage of corneas after exposure by the test substance.
2) In vitro EpiOcularTM
The test was performed according to theOECD Test Guideline No. 492: Reconstructed human Cornea-like Epithelium (RhCE) test method for identifying chemicals not requiring classification and labelling for eye irritation or serious eye damage. Details of the procedure are given in Protocol: EpiOcularTMEye Irritation Test (OCL-200-EIT) for the prediction of acute ocular irritation of chemicals (MatTek 06/29/2015).GLP study, Klimish score 1.
Value: The effect of the test substance was positive in EpiOcularTMmodel (tissues were damaged). The test substance is identified as potentially requiring classification and labelling according to UN GHS (Category 2 or Category 1).
3) QSAR Toolbox prediction: Model name: BfR eye irritation/corrosion
Predicted value: not irritating or corrosive to eye
Based on the available results of the test substance Acid Black 227 is classified as a skin irritant Category 2.
Based on the available results of the test substance Acid Black 227 is classified as an eye irritant Category 2.
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 17.01. - 31.03.2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- 2015
- Deviations:
- yes
- Remarks:
- See any other information...
- GLP compliance:
- yes (incl. QA statement)
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- other: normal human-derived epidermal keratinocytes
- Cell source:
- skin obtained from plastic surgery from multiple donors
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE- Model used: model EpiDermTM- Tissue: The reconstructed human epidermal model EpiDerm™ (EPI-200 ver. 2.0, MatTek, Bratislava, Slovakia); Lot No. 25802 kit C)- Date of initiation of testing: 30.6.2016The EpiDerm™ tissues (surface 0.63 cm²) are cultured on specially prepared cell culture inserts and shipped as kits, containing tissues on shipping agarose together with the necessary amount of culture media.TEMPERATURE USED FOR TEST SYSTEM- Temperature used during treatment / exposure: 37±1°C
- Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL- Amount(s) applied: 25 gNEGATIVE CONTROLPBS MatTek 101816ZSA, exp. 18/10/2017 - Amount(s) applied: 25 µLPOSITIVE CONTROL5 % SDS (sodium dodecyl sulphate), MatTek, Lot No. 031617MGKA, exp. 16/03/2018
- Duration of treatment / exposure:
- 60 min.
- Duration of post-treatment incubation (if applicable):
- 42 hours
- Number of replicates:
- 3
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- in the first experiment
- Value:
- 36.9
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- positive indication of irritation
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- in the second experiment, after correction
- Value:
- 25.8
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- positive indication of irritation
- Other effects / acceptance of results:
- Direct MTT reduction - functional check in tubes The test was not performed due to blue colour of the test substance. The next step was performed directly.
- Interpretation of results:
- other: The test substance is identified as requiring classification and labelling according to UN GHS (Category 2 or Category 1). As the test substance was not tested for skin corrosion, it is not possible to decide between these two categories.
- Conclusions:
- Under the above-described experimental design, average viability of tissues treated by the test substance Acid Black 227 was 36.9 % and 25.8% of negative control average value i.e. viability was < 50 % in both cases. The effect of the test substance was positive in EpiDermTM model. The test substance, Acid Black 227, is identified as requiring classification and labelling according to UN GHS (Category 2 or Category 1). As the test substance was not tested for skin corrosion, it is not possible to decide between these two categories.
- Executive summary:
The test substance, Acid Black 227, was assayed for in vitro skin irritation in the human epidermal model EpiDermTM. The test was performed according to the OECD Test Guideline No. 439: In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method (2015) and Protocol for: In Vitro EpiDermTM Skin Irritation Test For use with MatTek Corporation’s Reconstructed Human Epidermal Model EPI-200-SIT (see par. 1.4).
In the preliminary experiments neither colour interference with the endpoint nor direct MTT reduction were found.
After pre-incubation of tissues, 25 mg of the test substance was placed directly on previously moistened tissue and spread on the entire tissue surface. The length of exposure was 60 minutes. Three tissues were used for the test substance and for positive and negative controls.
After removal of the test substance, tissues were post-incubated for approximately 42 hours. Three hours incubation with MTT and two hours extraction period with shaking followed then. Optical density (OD570) of isopropyl alcohol extracts was measured on a spectrophotometer. Relative cell viability was calculated for each tissue as % of the mean viability of the negative control tissues.
Under the above-described experimental design average viability of treated tissues was 36.9 % in the first and 25.8 % (after correction) in the second experiment, i.e. viability was < 50 %.
The effect of the test substance was positive in EpiDermTM model (tissues were damaged).
The test substance is identified as requiring classification and labelling according to UN GHS (Category 2 or Category 1). As the test substance was not tested for skin corrosion, it is not possible to decide between these two categories.
- Endpoint:
- skin irritation / corrosion, other
- Type of information:
- (Q)SAR
- Adequacy of study:
- supporting study
- Justification for type of information:
- 1. SOFTWAREQSAR Toolbox 3.4.0.172. MODELBfR skin irritation/corrosion3. SMILES OR OTHER IDENTIFIERS USED AS INPUT FOR THE MODEL[Na+].O=N(=O)c8ccc(/N=N/c6c7ccccc7ccc6O[Cr]3Oc4ccc5ccccc5c4N=Nc1c(cc(c2ccccc12)S([O-])(=O)=O)O3)c(O)c8
- Qualifier:
- no guideline required
- Principles of method if other than guideline:
- BfR skin irritation/corrosion
- Specific details on test material used for the study:
- SMILE: [Na+].O=N(=O)c8ccc(/N=N/c6c7ccccc7ccc6O[Cr]3Oc4ccc5ccccc5c4N=Nc1c(cc(c2ccccc12)S([O-])(=O)=O)O3)c(O)c8
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- Toxicity of the target chemical (Not Irritating or Corrosive to skin) is predicted by QSAR "BfR skin irritation/corrosion".
- Executive summary:
Predicted value: not irritating or corrosive to skin
Referenceopen allclose all
Table 1: The first experiment: OD570 values obtained at the MTT test, their averages, standard deviations (%) and relative viabilities
Treatment | OD570 |
|
|
| Avg | SD | %NC | |
PBS (NC) | 2.022 | 1.940 | 2.050 | NT | NT | 2.004 | 0.047 |
|
viability (%NC) | 100.9 | 96.8 | 102.3 | - | - | 100.0 | 2.3 | 100.0 |
394/16 (C4) | 0.455 | 1.727 | 0.730 | 0.364 | 0.416 | 0.738 | 0.510 |
|
viability (%NC) | 22.7 | 86.2 | 36.4 | 18.2 | 20.8 | 36.9 | 25.5 | 36.9 |
5% SDS (PC) | 0.044 | 0.051 | 0.050 | NT | NT | 0.048 | 0.003 |
|
viability (%NC) | 2.2 | 2.5 | 2.5 | - | - | 2.4 | 0.2 | 2.4 |
Table 2: The second experiment: OD570 values obtained at the MTT test, their averages, standard deviations (%) and relative viabilities
Treatment | OD570 |
|
| Avg | SD | %NC |
PBS (NC) | 1.961 | 1.946 | 1.941 | 1.949 | 0.008 |
|
viability (%NC) | 100.6 | 99.8 | 99.6 | 100.0 | 0.4 | 100.0 |
394/16 (C3) | 0.282* | 0.264 | 1.098 | 0.548 | 0.389 |
|
viability (%NC) | 14.5 | 13.5 | 56.3 | 28.1 | 20.0 | 28.1 |
394/16 (C3_CC) | 0.049* | 0.042+ | NT | 0.046 | 0.004 |
|
viability (%NC) | 2.5 | 2.2 | - | 2.3 | 0.2 | 2.3 |
5% SDS (PC) | 0.059 | 0.053 | 0.056 | 0.056 | 0.002 |
|
viability (%NC) | 3.0 | 2.7 | 2.9 | 2.9 | 0.1 | 2.9 |
NC, PC | negative, positive control |
C3, C4, 394/16 | test substance |
avg | arithmetic average |
SD | standard deviation calculated from individual % tissue viabilities |
viability (%) | viability of single tissues compared with negative control |
NT | not tested |
* | damaged tissue (with lost of part of tissue) |
+ | damaged tissue (without lost of part of tissue) |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 20.06. - 22.06.2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- Adopted: 28 July 2015
- Deviations:
- yes
- Remarks:
- The difference of viability between the positive control tissues of was > 18%. Average viability was 28.9% what is < 50%. The highest (outlying) viability is 45.2% what is < 50% as well.
- GLP compliance:
- yes (incl. QA statement)
- Details on test animals or tissues and environmental conditions:
- The reconstructed human cornea-like epithelial model EpiOcular™ (OCL-200 ver. 2.0) comes from MatTek, Bratislava, SK. The RhCE tissues are reconstructed from primary human cells, which have been cultured for several days to form a stratified, highly differentiated squamous epithelium, morphologically similar to that found in the human cornea. The EpiOcular™ RhCE tissue construct consists of at least 3 viable layers of cells and a non-keratinized surface, showing a cornea-like structure analogous to that found in vivo.
- Vehicle:
- physiological saline
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- The test substance (50 mg of substance/surface ratio 39.7 mg/cm2) is placed directly atop to the tissue moistened with 20 µL of PBS.
- Duration of treatment / exposure:
- 6h
- Duration of post- treatment incubation (in vitro):
- after removal:post-soaked-25 min.post-incubation-18 hours
- Number of animals or in vitro replicates:
- two replicate tissues
- Details on study design:
- Temperature: 37±1°C3 tissues for the test substance3 tissues for every control2 tissues as colorant controlTest ProcedureOn the day of receipt, EpiOcularTM tissues are conditioned to release transport stress related compounds and debris by incubation in assay medium delivered by MatTek for test performance for 1 hour at standard culture conditions and, after media replacement, overnight (following 16-24 hours) also standard at culture conditions. After pre-incubations, tissues are wetted with 20 μl of PBS spread across entire tissue surface. After 30 minutes incubation tissues are topically exposed to the test chemical (50 mg per tissue) for 6 ± 0.25 hours. Four tissues (2 for MTT test 2 for colorant control) are used per test substance (TS) and two for the positive control (PC) and negative control (NC). At the end of the 6±0.25 hours treatment time, the test articles should be removed by extensively rinsing the tissues with PBS brought to room temperature. After rinsing, tissues are immediately transferred to and immersed in 5 ml of previously warmed assay medium (room temperature) in a pre-labelled 12-well plate for a 25 ± 2 minute immersion incubation (post-soak) at room temperature. This incubation in assay medium is intended to remove any test article absorbed into the tissue. At the end of the post-soak immersion, each insert is removed from the assay medium, the medium is decanted off the tissue, and the insert is blotted on absorbent material and transferred to the appropriate well of the pre-labelled 6-well plate containing 1 ml of warm assay medium. The tissues should be incubated for 18±0.25 hours at standard culture conditions (post-treatment incubation). At the end of the post-treatment incubation, each insert is removed from the 6-well plate and gently blotted on absorbent material. Two tissues are placed into the 24-well plate containing 0.3 ml of MTT solution and incubated for 180±10 minutes at standard culture conditions. Two tissues undergo the same procedure with medium instead MTT solution (colorant control).In the end of staining (incubation with medium) the bottom of all inserts is blotted on absorbent material, and inserts are then transferred to a pre-labelled 6-well plate containing 2 ml of isopropyl alcohol in each well so that no isopropyl alcohol is flowing into the insert. The plates are sealed with parafilm, and are either stored overnight at 2-8°C in the dark or immediately extracted. To extract the MTT, the plates are placed on an orbital plate shaker and shaken for 2 to 3 hours at room temperature. After extraction extracts are collected, mixed and two 200 μl aliquots are transferred to the appropriate wells of a pre-labeled 96-well plate for OD570 reading.
- Irritation parameter:
- other: viability of treated tissues
- Run / experiment:
- 1
- Value:
- -2.7
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- positive indication of irritation
- Interpretation of results:
- Category 2 (irritating to eyes) based on GHS criteria
- Conclusions:
- Under the above-described experimental design, average viability of tissues treated by the test substance Acid Black 227 was -2.7 % (after correction) of negative control average value. The effect of the test substance was positive in EpiOcularTM model (tissues were damaged). According to the classification criteria given in chapter 4.5., the test substance, Acid Black 227, is identified as substance potentially requiring classification and labelling according to UN GHS (Category 2 or Category 1).
- Executive summary:
The test substance, Acid Black 227, was assayed for the in vitro eye irritation in human epidermal model EpiOcularTM. The test was performed according to the OECD Test Guideline No. 492: Reconstructed human Cornea-like Epithelium (RhCE) test method for identifying chemicals not requiring classification and labelling for eye irritation or serious eye damage. Details of the procedure are given in Protocol: EpiOcular™ Eye Irritation Test (OCL-200-EIT) for the prediction of acute ocular irritation of chemicals (MatTek 06/29/2015).
After pre-incubation and wetting of tissues, 50 mg of the test substance was placed directly atop to the tissue and it was spread on the entire tissue surface. Length of exposition was 6 hours at 37±1°C in humidified CO2 incubator (5±1% CO2). Three tissues were used for the test substance and every control. Two tissues more were used as colorant control to correction of possible colour interference, which was undergo the entire testing procedure excepting of incubation with MTT medium.
After removal of the test substance, tissues were post-soaked in medium for approximately 25 minutes and post-incubated for about 18 hours at culture conditions. Three hours incubation with MTT and two hours extraction period with shaking followed then. Optical density (OD570) of isopropyl alcohol extracts was measured on a plate reader. Relative cell viability was calculated for each tissue as % of the mean viability of the negative control tissues.
Test for colour interference revealed direct reduction caused with the test substance. “Viability” of tissues treated by the test substance was corrected.
Test for direct reduction was performed as a part of another study. Direct reduction was not discernible. With regard to the result of MTT, test assay in frozen tissues was not performed.
Under the above-described experimental design average viability of treated tissues was -2.7 % (after correction) i.e. viability was ≤ 60 %.
The effect of the test substance was positive in EpiOcularTM model (tissues were damaged).
According to the classification criteria given in chapter 4.5., the test substance, Acid Black 227, is identified as substance potentially requiring classification and labelling according to UN GHS (Category 2 or Category 1). Further testing with other test methods will be required.
Reference
Table No. 1: OD570 values obtained at the MTT test, their averages, standard deviations (%) and relative viabilities.
Treatment | OD570 (tissue 1,2,3) | Avg | SD | %NC | ||
water (NC) | 1.906 | 1.919 | 1.967 | 1.931 | 0.026 |
|
viability (%NC) | 98.7 | 99.4 | 101.9 | 100.0 | 1.4 | 100.0 |
394/16 (C5) | 0.509 | 0.498 | 0.644 | 0.550 | 0.066 |
|
viability (%NC) | 26.4 | 25.8 | 33.4 | 28.5 | 12.0 | 28.5 |
394/16 (C5_CC) | 0.654 | 0.551 | - | 0.603 | 0.052 |
|
viability (%NC) | 33.9 | 28.5 | - | 31.2 | 8.6 | 31.2 |
99% MA (PC) | 0.872 | 0.442 | 0.359 | 0.558 | 0.225 |
|
viability (%NC) | 45.2 | 22.9 | 18.6 | 28.9 | 40.3 | 28.9 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.